To investigate the effects of 99 Tc-MDP, a decay product of 99m Tc-MDP, on the development of choroidal neovascularization (CNV), together with its underlying mechanisms.
C horoidal neovascularization (CNV) is the key pathogenesis in exudative form of age-related macular degeneration (AMD), the leading cause of blindness among the elderly in developed countries. 1 CNV is immature new blood vessel that penetrates the Bruch's membrane and extends into the subretinal or subretinal pigment epithelium space. It often leads to loss of central vision by exudation and hemorrhage, retinal pigment epithelial (RPE) or retinal detachment, photoreceptor degeneration, and the formation of disciform scars. 2 The exact mechanisms of CNV formation have not been fully elucidated. Recent studies demonstrate an important role of inflammatory mechanisms in CNV of AMD patients 3, 4 and in experimental CNV models. 5, 6 The inflammatory processes include macrophage infiltration and a variety of inflammatory cytokine networks. This concept of inflammation-mediated neovascularization is further supported by studies that generalized macrophage depletion reduced the size and leakage of laser-induced CNV associated with decreased macrophage infiltration and VEGF protein expression. 7, 8 Inflammation-related molecules, such as intercellular adhesion molecule (ICAM)-1, 9,10 tumor necrosis factor (TNF)-␣, 11, 12 and matrix metalloproteinases (MMPs), 13 express at a higher level than normal in CNV patients and laser-induced animal models. Since inflammation-related cells and molecules play an important role in the development of CNV, it is reasonable to hypothesize that the regulation of inflammation may be a promising therapeutic strategy to inhibit CNV.
Technetium-99 conjugated with methylene diphosphonate (Yunke; 99 Tc-MDP) is a kind of anti-inflammatory drug patented in China (patent no. ZL94113006.1) that has been demonstrated to be safe and effective in the clinical treatment of rheumatoid arthritis (RA) and ankylosing spondylitis (AS) in China. 14 -17 The chemical structure of 99 Tc-MDP is shown in Figure 1 .
99 Tc-MDP is actually the decay product of 99m Tc-MDP ( 99m Tc-methylene diphosphonate, a US Food and Drug Administration-approved radioactive agent widely used for bone scintigraphy). Unlike 99m Tc-MDP, 99 Tc-MDP has little of the intensity of radioactivity demonstrated to be harmless to the human body. 99 Tc-MDP treatment can lead to decreased serum levels of TNF-␣ and IL-1␤, which are commonly accepted as proinflammatory factors 18 in the rat model of adjuvant arthritis 19 and in patients with RA. 15 Because IL-1 is the chemoattractant for leukocytes, 99 Tc-MDP is supposed to have the ability to inhibit leukocyte migration. 15 At the same time 99 Tc-MDP promotes the scavenging of free radicals and activates superoxide dismutase; therefore, it can prevent the tissue damage caused by free radicals.
14 Considering the similarity of pathogenesis between AMD and systemic inflammation-related diseases, we used the anti-inflammatory property of 99 Tc-MDP to investigate its effects on the development of CNV.
To our knowledge, no data have been presented concerning the effects of 99 Tc-MDP on CNV development. Here we report the first evidence of the in vivo and in vitro inhibitive effects of 99 Tc-MDP on the development of CNV together with the underlying cellular and molecular anti-inflammatory mechanisms.
MATERIALS AND METHODS

Preparation of 99 Tc-MDP
Yunke (Chengdu Yunke Pharmaceutical, Sichuan, China) contains two preparations. Preparation A is a 5-mL vial of colorless transparent solution containing 0.05 g 99 Tc. Preparation B is a lyophilized white powder that contains 5 mg methylene diphosphonic acid (MDP) and 0.5 mg stannous chloride.
99 Tc-MDP should be prepared before use by injecting preparation A into preparation B. According to the instruction manual, both preparations should be stored at 2°C to 8°C in a dark environment.
Animals
Male C57BL/6J mice aged 6 to 8 weeks (SPF level) were purchased from the Animal Experiment Center of Sun Yat-sen University. All animals used in this study were treated in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.
Induction of CNV and Intraperitoneal Injection of 99
Tc-MDP
Mice were anesthetized by intramuscular injection of 100 mg/kg body weight (BW) ketamine hydrochloride, and pupils were dilated with 0.5% tropicamide-phenylephrine ophthalmic solution (Mydrin; Santen Pharmaceutical, Osaka, Japan). Four laser burns (50-m spot size, 0.05-second duration, 250-mW power) were placed at a distance of 2 to 3 PD around the optic nerve with a frequency-doubled Nd:YAG laser (Novus Spectra; Lumenis Inc, Santa Clara, CA) using the slit lamp delivery system (Haag-Streit, Mason, OH) and a coverslip as a contact lens, as previously described. 20 Production of a cavitation bubble at the laser point is thought to be the sign of disruption of Bruch's membrane, which leads to the formation of CNV. 20 Therefore, only burns with bubbles were included in this study. The treatment groups were intraperitoneally injected daily until the end of experiment with 99 Tc-MDP at the dose of 0.5 ϫ 10 Ϫ1 g/kg BW, 1 ϫ 10 Ϫ1 g/kg BW, or 2 ϫ 10 Ϫ1 g/kg BW immediately after laser photocoagulation and the control group was intraperitoneally injected daily with the same volume of PBS.
Preparation and Quantitative Analysis of Choroidal Flatmounts
One week after laser photocoagulation, mice were anesthetized and perfused with 1 mL PBS containing 50 mg/mL fluorescein-labeled dextran (2 ϫ 10 6 average MW; Sigma, St. Louis, MO) through the left ventricle, as previously described. 21 The eyes were enucleated and fixed in 4% paraformaldehyde for 1 hour at room temperature. The anterior segment and neurosensory retina were carefully removed; after that, four to six radial relaxing incisions were made from the edge to the equator to allow the remaining RPE-choroid-sclera complex to be flattened on a glass slide with the RPE facing up. Then a coverglass was placed on the choroidal flatmount with mounting medium (Vectashield; Vector Laboratories, Burlingame, CA). CNVs on the flatmounts were examined by fluorescence microscopy (Axioplan 2 imaging; Zeiss, Thornwood, NY), and the CNV images were digitized. Areas of CNV that were associated with hyperfluorescence (n ϭ 13 in each group) were then measured (Image-Pro Plus 6.0 software; Media Cybernetics, Silver Spring, MD).
Immunofluorescence for Infiltrating Macrophages
Whole mounts of RPE-choroid-sclera complexes were obtained 3 days after photocoagulation (11-12 mice were used in each group). The complexes were incubated at 4°C overnight with a goat polyclonal antibody against mouse PECAM-1 (CD31; Santa Cruz Biotechnology, Santa Cruz, CA) and a rat polyclonal antibody against F4/80 (Serotec, Oxford, UK) followed by incubation with Avidin-Alexa 488 -tagged and Avidin-Alexa 555-tagged secondary antibodies (Alexa 488 and Alexa 555; Invitrogen, Carlsbad, CA) for 2 hours at room temperature, as described previously. 22 After that, PECAM-1-stained CNV areas and F4/80 positive infiltrating macrophages were scanned with a scanning laser confocal microscope (LSM710; Zeiss) in 5-m steps, and numbers of macrophages per laser lesion were calculated by image processing and analysis software (Imaris 7.0; Bitplane, Zurich, Switzerland).
ELISA for VEGF and Inflammation-Related Molecules
Three days after laser photocoagulation, RPE-choroid complexes were harvested from the RPE-choroid-sclera flatmount under a dissecting microscope, using a slit knife with its edge completely dull. After that, two RPE-choroid complexes from the right and left eyes of the same mouse were placed together into 500 L lysis buffer supplemented with protease inhibitors (Sigma), as previously described, 23 and then were carefully homogenized with glass tissue homogenizer. Then the lysate was cleared of debris by centrifugation at 12,000 rpm for 10 minutes at 4°C. The levels of VEGF (n ϭ 7 or 8 mice in each group), ICAM-1 (n ϭ 12), and TNF-␣ (n ϭ 12) in the supernatant were determined with the mouse VEGF, ICAM-1, and TNF-␣ ELISA kits (R&D Systems Inc., Minneapolis, MN) and normalized to total protein (determined by DC protein assay kit; Bio-Rad Laboratories) according to the instruction manual. Specially, the VEGF ELISA kit recognizes all the isoforms of VEGF.
Gelatin Zymography for Activity of MMP-2 and MMP-9
Gelatin zymography was used to detect the protein of MMP-2 and MMP-9 expressed in RPE-choroid complexes 3 days after laser injury. Zymography was performed as described by Munaut et al. 24 with some modifications. Briefly, 30 L homogenate supernatant of the RPEchoroid complex (contained 30 g total protein, determined by DC protein assay kit; Bio-Rad Laboratories) was added to each lane and electrophoresed in 10% sodium dodecyl sulfate (SDS)-polyacrylamide with 1 mg/mL gelatin (Sigma). The gels were soaked in wash buffer (Triton; Sigma), then stained overnight with Coomassie brilliant blue and destained with methanol and acetic acid. Zones of clearing in the gel indicated MMP activity, and the gray intensity value of the proteolytic zone of the gels compared with those of the PBS control group were calculated (ImageQuant software, version 5.2; Molecular Dynamics, Sunnyvale, CA).
Real-Time PCR for mRNA Expression of MMP-2
Total RNA was isolated (Trizol; Invitrogen) from the RPE-choroid complexes 3 days after photocoagulation. RPE-choroid complexes from both eyes of a mouse were pooled for analysis as the sample for this mouse (five mice in each group). Yield and purity were determined photometrically. Complementary DNA synthesis was performed with a first-strand DNA synthesis kit (QuantiScript; Qiagen, Valencia, CA) and then was quantified by real-time PCR analysis (ABI7500; Applied Biosystems, Carlsbad, CA). Sequences of the PCR primers were as follows: (MMP-2) forward primer, 5Ј-GCCCCCATGAAGCCT-TGT-3Ј; reverse primer, 5Ј-TTGTAGGAGGTGCCCTGGAA-3Ј; probe, 5Ј-FAM-TGGCAATGCAGATGGACAGCCC-TAMRA-3Ј; (␤-actin) forward primer, 5Ј-GCGCGGCTACAGCTTCA-3Ј; reverse primer, 5Ј-TCTCCTTA-ATGTCACGCACGAT-3Ј; probe, 5Ј-FAM-CACCACGGCCGAGCGGGA-TAMRA-3Ј. The PCR mix was denatured at 93°C for 3 minutes, followed by 40 cycles of melting at 93°C for 15 seconds, annealing at 55°C for 32 seconds, and elongation at 72°C for 32 seconds. The data were normalized relative to ␤-actin mRNA levels.
ERG for Toxicity of 99 Tc-MDP on Retina In Vivo
ERG recordings were performed both at baseline (before the first injection of 99 Tc-MDP) and 7 days after intraperitoneal injection daily with 99 Tc-MDP at the doses of 0.5 ϫ 10 Ϫ1 g/kg BW (n ϭ 5), 1 ϫ 10
Ϫ1
g/kg BW (n ϭ 5), 2 ϫ 10 Ϫ1 g/kg BW (n ϭ 5), or the same volume of PBS (n ϭ 5). The mice were kept in the dark environment for 12 hours and were prepared under dim red illumination, and then flash ERG recordings were performed in the right eye (RETIport; Roland Consult, Brandenburg, Germany), as previously described. 25 Briefly, mice were anesthetized and were placed on a heating pad with a constant temperature of 39°C throughout the experiment. Pupils were dilated with 0.5% tropicamide-phenylephrine ophthalmic solution (Mydrin; Santen Pharmaceutical, Osaka, Japan), and corneas were anesthetized with a drop of 0.5% proparacaine hydrochloride (Alcon, Puurs, Belgium). Custom gold wire electrodes were placed on the corneas. Reference and ground electrodes were placed subcutaneously between the eyes and inserted into the tails, respectively. Eyes were stimulated with 3 cd ⅐ s/m 2 intensity levels of white light by a lightemitting diode photostimulator (Ganzfeld Q450; Roland Consult) at 10-s duration and 9-second interval for each stimulus. Averages of 20 responses were calculated, and the a-wave and b-wave amplitudes and b-wave implicit times were recorded; a-wave and b-wave amplitudes and b-wave implicit times of the flash ERGs were compared between the pre-and post-99 Tc-MDP treatment groups.
In Vitro Assays
Proliferation and Cytotoxicity of Cells. Effects of 99 Tc-MDP on the proliferation of RF/6A cells (rhesus macaque choroidretinal endothelial cell; purchased from the Institute of Biochemistry and Cell Biology, Shanghai, China) were estimated by bromodeoxyuridine (BrdU) assay. Cells were seeded into 96-well plates with a density of 1 ϫ 10 4 cells/well. Blank control (wells without cells) and background (wells with cells but without 99 Tc-MDP treatment) were used. One day after plating (cells were still nonconfluent and dividing at this time), the medium was removed and the cells were incubated with serum-free medium with or without 99 Tc-MDP (n ϭ 6) (0.50 ϫ 10 Ϫ1 g/mL, 0.25 ϫ 10 Ϫ1 g/mL, or 0.125 ϫ 10 Ϫ1 g/mL) for 12 hours. BrdU label (20 L; Sigma) was added to each well (except background wells) together with the 99 Tc-MDP treatment. Then cells were fixed and permeabilized and the DNA was denatured, followed by incubation with anti-BrdU antibody (Sigma) for 1 hour. The unbound antibody was washed away, and horseradish peroxidase-conjugated goat anti-mouse antibody (Boster, Wuhan, China) was added to each well and incubated for 30 minute. Finally, chromogenic substrate tetra-methylbenzidine (R&D Systems Inc.) was added, and the absorbance of the color was measured with a microplate reader at 450-nm wavelength.
MTT assay was used to determine the cytotoxicity of 99 Tc-MDP on nondividing RF/6A cells. Cells at a density of 5 ϫ 10 3 per well were plated in 96-well plates and grown until confluence. After confluence, cells were incubated with 99 Tc-MDP solutions from 0.05, 0.025, and 0.0125 g/mL or PBS (n ϭ 8) for 12 hours. 99 Tc-MDP solutions were then drilled out, and 180 L medium with 20 L MTT (5 mg/mL) was added to each well; this was followed by incubation for 4 hours at 37°C. After that, all media were carefully removed. Then 150 L dimethyl sulfoxide was added to each well to dissolve the formazan crystals. Ten minutes later, the plate was read at a wavelength of 490 nm. Cell viability was compared on the basis of the OD 490 value. The experiment was repeated three times.
Cell Migration Assay. RF/6A cell migration assay was performed using 50 g/mL fibronectin (Biological Industries Ltd., Kibbutz Beit Haemek, Israel)-coated, 24-well permeable cell inserts (Boyden chamber, Transwell; Corning Costar, Corning, NY) with 8-m pore size, as described previously with some modifications. 26 Briefly, chemotaxis was induced by the addition of 800 L Dulbecco's modified Eagle medium (DMEM) with 0.1% bovine serum albumin (BSA; Sigma), with or without 10 ng/mL VEGF (R&D Systems Inc.) to the lower compartment. Serum-free DMEM (200 L) with 0.1% BSA of 1 ϫ 10 5 RF/6A cells per well were loaded onto the upper compartment with or without 99 Tc-MDP (0.50 ϫ 10 Ϫ1 g/mL, 0.25 ϫ 10 Ϫ1 g/mL, or 0.125 ϫ 10 Ϫ1 g/mL). The transwell units were then incubated at 37°C (95% air/5% CO 2 ) for 6 hours. The filters were fixed and stained with hematoxylin; nonmigrated cells (on top of the filters) were wiped with a cotton bud, and then the remaining filters with the migrated cells were mounted on a glass slide. Four randomly chosen fields were photographed per filter (ϫ 20 objective), and the numbers of migrated cells were counted. The experiment was repeated three times.
Tube Formation Assay. For capillary-like tube formation assay, 50 L basement membrane extract (BME; R&D Systems Inc.) was used to coat each well of a 24-well plate, followed by polymerization at 37°C for 30 minutes. RF/6A cells were cultured in DMEM with 1% fetal bovine serum (FBS) overnight. Trypsin-harvested cells (3. Ϫ1 g/mL, or 0.125 ϫ 10 Ϫ1 g/mL) were seeded onto BME-coated plates and incubated at 37°C for 6 hours. To evaluate the lengths of the capillary-like vessels on the BME, four photographs in different randomly selected fields around the center of each well were taken with a phase-contrast microscope (ϫ10 objective). The lengths of the tube were measured (Image-Pro Plus 6.0 software; Media Cybernetics). The experiment was also repeated three times.
Statistical Analysis
Data were expressed as mean Ϯ SD and were tested for significance using one-way ANOVA. A confidence level of P Ͻ 0.05 was considered statistically significant. All analyses were performed statistical software (SAS 8.1; SAS Institute, Inc., Cary, NC).
RESULTS
Suppression of CNV in Mice Receiving
99 Tc-MDP Seven days after laser photocoagulation, CNVs on RPE-choroidsclera flat mounts examined by fluorescence microscopy showed that 99 Tc-MDP significantly suppressed the development of CNV in a dose-dependent manner (Fig. 2) .
99 Tc-MDP treatment of 0.5 ϫ 10 Ϫ1 g/kg (5698.60 Ϯ 1037.70 m 2 , P Ͻ 0.001; n ϭ 13), 1 ϫ 10 Ϫ1 g/kg (3678.34 Ϯ 1328.18 m 2 , P Ͻ 0.001; n ϭ 13), and 2 ϫ 10 Ϫ1 g/kg (2365.78 Ϯ 923.80 m 2 , P Ͻ 0.001; n ϭ 13) could respectively suppress the CNV areas by 36.12%, 58.76%, and 73.48% compared with PBS treatment group (8920.36 Ϯ 1097.29 m 2 ; n ϭ 13).
Inhibitive Effects of 99 Tc-MDP on Macrophage Infiltration
We quantitated the infiltration of macrophages in CNV with an immunofluorescence method. The numbers of macrophages per laser lesion were calculated to determine whether 99 Tc-MDP had an inhibitive effect on the macrophage infiltration. Immunofluorescence intensity for F4/80 tended to be lower in the 99 Tc-MDPtreated mice than in the PBS-treated mice (Fig. 3A) , and 99 Tc-MDP had the ability to decrease the numbers of infiltrating macrophages in a dose-dependent manner (n ϭ 11-12) (Fig. 3B) .
Inhibition of VEGF and Inflammatory Molecules by the Treatment of 99 Tc-MDP
Macrophages invaded the site of laser injury within 1 day, and peak macrophage numbers paralleled the maximal amount of VEGF protein detected in the RPE-choroid complexes 3 days after laser photocoagulation. 7 Therefore, to determine whether the protein level of VEGF and inflammatory molecules had the parallel relationship with the numbers of infiltrating macrophages, we collected RPE-choroid complexes 3 days after laser photocoagulation and detected protein levels of VEGF, ICAM-1, and TNF-␣ in the RPE-choroid complex by using ELISA. The results showed that 99 Tc-MDP treatment significantly suppressed protein levels of VEGF (n ϭ 7-8), ICAM-1 (n ϭ 12), and TNF-␣ (n ϭ 12) compared with the PBS treatment group (P Ͻ 0.05 for all) (Figs. 3C-E) . However, for VEGF, there was no statistical significance between the 1 ϫ 10 Ϫ1 g/kg BW group and the 2 ϫ 10 Ϫ1 g/kg BW group (P Ͼ 0.05) or between the 1 ϫ 10 Ϫ1 g/kg BW group and the 0.5 ϫ 10
Ϫ1
g/kg BW group (P Ͼ 0.05). For ICAM-1, there was no statistical significance between the 1 ϫ 10 Ϫ1 g/kg BW group and the 2 ϫ 10 Ϫ1 g/kg BW group (P Ͼ 0.05). For TNF-␣, although there was statistical significance between the 99 Tc-MDP-treated groups and the PBS-treated group (P Ͻ 0.01), there was no statistical significance between any two of the 99 Tc-MDP-treated groups (P Ͼ 0.05). Tc-MDP in a dose-dependent manner. ***P Ͻ 0.001 compared with the PBS control group; n ϭ 13. Scale bars, 50 m (A-D).
Inhibition of MMP-2 Activity by Zymography
Gelatin zymography is a sensitive technique that detects activated gelatin-degrading metalloproteinases such as MMP-2 and MMP-9. 27 Cultured supernatant of the human HT1080 cell was used as a molecular weight marker. The gray intensity value of the proteolytic zone of the gels in the 99 Tc-MDP-treated group was much lower than in the PBS control group for active MMP-2 (P Ͻ 0.01; n ϭ 9) but not for pro-MMP-9 (P Ͼ 0.05; n ϭ 9), as is shown in Figure 4 .
Inhibition of mRNA Expression of MMP-2 by Real-Time PCR
Real-Time PCR was used to determine MMP-2 mRNA expression in RPE-choroid complexes 3 days after photocoagulation.
Š
FIGURE 3. Inhibitive effects of
99 Tc-MDP on macrophage infiltration together with downregulated protein levels of VEGF and inflammatory molecules. Three days after photocoagulation, the infiltration of macrophages in CNV was quantitated by immunofluorescence, and the protein levels of VEGF, ICAM-1, and TNF-␣ in the RPE-choroid complex were measured by ELISA. (A) F4/80-positive macrophages (top, green, white arrows) and PECAM-1-stained CNV areas (bottom, red) showed that immunofluorescence intensity for F4/80 tended to be lower in the 99 Tc-MDP-treated mice than in the PBS-treated mice. Scale bars, 50 m. (B) 99 Tc-MDP inhibited the infiltration of macrophages into the CNV compared with the PBS-treated group by calculating the numbers of macrophages per laser lesion (*P Ͻ 0.05, **P Ͻ 0.01; n ϭ 11-12). (C-E) The protein levels of VEGF (*P Ͻ 0.05, **P Ͻ 0.01; n ϭ 7-8), ICAM-1 (*P Ͻ 0.05, **P Ͻ 0.01; n ϭ 12), and TNF-␣ (**P Ͻ 0.01; n ϭ 12) were significantly suppressed by the treatment of 99 Tc-MDP compared with the PBS control group. For VEGF, there was no statistical significance between the 1 ϫ 10 Ϫ1 g/kg BW group and the 2 ϫ 10 Ϫ1 g/kg BW group (P Ͼ 0.05) or between the 1 ϫ 10 Ϫ1 g/kg BW group and the 0.5 ϫ 10 Ϫ1 g/kg BW group (P Ͼ 0.05). For ICAM-1, there was no statistical significance between the 1 ϫ 10 Ϫ1 g/kg BW group and the 2 ϫ 10 Ϫ1 g/kg BW group (P Ͼ 0.05). For TNF-␣, there was no statistical significance between any two of the 99 Tc-MDP-treated groups (P Ͼ 0.05). Tc-MDP-treated group was significantly lower than that in the PBS control group for the active MMP-2 (**P Ͻ 0.01; n ϭ 9) but not for pro-MMP-9 (P Ͼ 0.05; n ϭ 9).
MMP-2 mRNA expression was increased after photocoagulation (Fig. 5) , and 99 Tc-MDP inhibited MMP-2 mRNA expression in a dose-dependent manner compared with the PBS-treated group (P Ͻ 0.001; n ϭ 5).
ERG for Toxicity of 99 Tc-MDP on Retina In Vivo
Representative ERG responses were shown in Figure 6 . There was no statistically significant difference in a-and b-wave amplitudes or in b-wave implicit times of post-99 Tc-MDP treatment compared with those of pre-99 Tc-MDP treatment in each group (P Ͼ 0.05; n ϭ 5) ( Table 1 ). ERG data suggested that 99 Tc-MDP had no influence on the function of retinal outer and inner layers.
Proliferation and Cytotoxicity of Cells In Vitro
In the BrdU assay we used dividing (not confluent) cells, which represented the pathologic condition of active CNV to some extent, to determine the antiproliferative effect of 99 Tc-MDP. The results showed that 99 Tc-MDP treatment had a significantly inhibitive effect on cell proliferation in a dose-dependent manner (Fig. 7A ) (P Ͻ 0.001; n ϭ 6). However, 99 Tc-MDP had no influence on completely confluent (nondividing) cells in the MTT assay (Fig. 7B ) (P Ͼ 0.05; n ϭ 8). The data suggested that 99 Tc-MDP was cytotoxic only to dividing cells.
In Vitro Inhibition of VEGF-Induced Migration and Tube Formation of RF/6A Cells
In the cell migration assay, as is shown in Figures 8A and 8B , stimulation by 10 ng/mL VEGF resulted in an increase of approximately 100% migration activity compared with the basal group (without VEGF in the culture medium).
99 Tc-MDP (0.0125-0.05 g/mL) significantly inhibited cell migration chemoattracted by 10 ng/mL VEGF in a concentration-dependent manner (P Ͻ 0.001; n ϭ 9) (Figs. 8C-F) . At the highest concentration of 99 Tc-MDP (0.05 g/mL), the number of migrated cells was suppressed by 76.78% compared with the PBS control group. In the VEGF-induced capillary-like vessel formation assay, VEGF significantly enhanced tube formation (Figs. 9A, 9B) . At the concentration of 0.025 g/mL 99 Tc-MDP, the length of the formed capillary-like vessel was suppressed to the basal group level (without VEGF in the culture medium) (Figs. 9A, 9D, 9E) . Figures 9C to 9E showed a decreasing tendency of annular structures and numbers of branch points of capillary-like vessels, especially in the 0.05-g/mL 99 Tc-MDP-treated group compared with the PBS control group. Vessel lengths were suppressed by the treatment of 99 Tc-MDP in a concentrationdependent fashion (Fig. 9F) (P Ͻ 0.001; n ϭ 12) .
These results demonstrated that 99 Tc-MDP had the ability to block VEGF-induced angiogenesis in vitro.
DISCUSSION
In this present study, our data for the first time revealed several important findings concerning the antiangiogenic effects of 99 Tc-MDP on the development of CNV with its anti-inflammatory property. First, 99 Tc-MDP significantly suppressed the development of CNV in murine models in vivo ( Fig. 2) and had an antiproliferative effect on the RF/6A cell in vitro in a dosedependent manner (Fig. 7A) . Second, 99 Tc-MDP inhibited VEGF-induced RF/6A cell migration and tube formation in vitro (Figs. 8, 9 ), both in a dose-dependent manner. Third, 99 Tc-MDP treatment decreased the numbers of macrophages infiltrating the CNV (Figs. 3A, 3B ), together with downregulated protein expression of VEGF (Fig. 3C ) and inflammatory molecules including ICAM-1 and TNF-␣ (Figs. 3D, 3E ). In addition, 99 Tc-MDP treatment inhibited the mRNA expression and gelatindegrading activity of MMP-2 (Figs. 4, 5) . Importantly, electroretinography and cytotoxicity study showed that any dose of 99 Tc-MDP used in our study was not toxic to the mouse retina (Fig. 6 ) or to nondividing (confluent) cells (Fig. 7B) . Tc-MDP. ERG recordings were performed both at baseline (before the first injection of 99Tc-MDP) and 7 days after daily intraperitoneal injection with 99 Tc-MDP at the dose of 0.5 ϫ 10 Ϫ1 g/kg BW (n ϭ 5), 1 ϫ 10 Ϫ1 g/kg BW (n ϭ 5), 2 ϫ 10 Ϫ1 g/kg BW (n ϭ 5), or the same volume of PBS (n ϭ 5). The male C57BL/6J mice aged 6 to 8 weeks were kept in the dark environment for 12 hours, and then flash ERG recordings were performed. There was no statistically significant difference in a-and b-wave amplitudes or in b-wave implicit times between pretreatment and posttreatment with 99 Tc-MDP in each group (P Ͼ 0.05; n ϭ 5). Real-time PCR analysis for the MMP-2 mRNA expression in RPE-choroid complexes 3 days after laser photocoagulation. Right and left RPE-choroid complexes from a mouse were pooled for analysis as the sample for this mouse. Data were normalized relative to ␤-actin mRNA levels. The y-axis represents the ratio of the mRNA level in 99 Tc-MDP-treated group to the PBS-treated group. MMP-2 mRNA expression was increased after photocoagulation (PBS-treated group compared with basal group [normal mice without laser photocoagulation]; ***P Ͻ 0.001; n ϭ 5). 99 Tc-MDP inhibited MMP-2 mRNA expression in a dose-dependent manner ( 99 Tc-MDP-treated group compared with the PBS-treated group; ***P Ͻ 0.001; n ϭ 5).
Angiogenesis is the formation of new blood vessels from preexisting vasculature. 28 As we know, the well-defined steps of angiogenesis include extracellular matrix (ECM) degradation, endothelial cell migration, cell proliferation, tube formation, and vessel wall remodeling. 29 Migration and tube formation of endothelial cells have been thought to be important steps in angiogenesis. 30 Our in vitro experimental data had shown that 99 Tc-MDP inhibited not only cell proliferation but also VEGF-induced cell migration and tube formation in a dose-dependent manner (Figs. 7A, 8, 9 ), which could be an important cellular mechanism for the inhibitive effects of 99 Tc-MDP on the CNV in vivo murine model. As discussed, ECM degradation is the initial step for endothelial cell migration. ECM degradation, which facilitates endothelial cell migration further into the subretinal space during angiogenesis, is thought to be a very important step in angiogenesis, 31 and this process is potentiated by the secretion of matrix metalloproteinases (MMPs). 32 Among MMPs, MMP-2 and MMP-9 are particularly noted by researchers because they preferentially degrade type IV collagenase (the main component of the basement membrane). 33 Mice with MMP-2 and MMP-9 gene deficiency have a decreased incidence and severity of laser-induced CNV. 34, 35 Our data showed that MMP-2 mRNA expression was upregulated in the PBS control group (with laser photocoagulation) compared with the non-lasertreated mouse group (basal group), and 99 Tc-MDP had the property of inhibiting MMP-2 mRNA expression in a dosedependent manner (Fig. 5) . Results of gelatin-degrading activity of MMP-2 paralleled the real-time PCR results (Figs. 4, 5) , and these results suggested that decreased gelatin-degrading activity of MMP-2 might be related to the reduced mRNA expression of MMP-2. Because MMP-2 can be directly secreted by macrophages 36 and MMP-2 mRNA expression can be upregulated by VEGF, 37 based on our data we propose that the inhibitive effects of 99 Tc-MDP on the mRNA expression of MMP-2, which directly leads to the decreased gelatin-degrading activity of MMP-2, are due to the suppression of infiltrating macrophages and the inhibited protein expression of VEGF.
Increasing evidence has supported the notion that inflammatory mechanisms play a role in the pathogenesis of CNV. 3, 4, 38, 39 As one of the most important inflammatory cells, macrophages play a critical role in the development of CNV. 4, 40, 41 By secreting growth factors and inflammatory cytokines, macrophages can influence every phase of the angiogenic process, such as alterations of the local extracellular matrix, migration, and proliferation of endothelial cells. 42 Blood-derived macrophages infiltrating the CNV are thought to be a rich source of VEGF. 43 Generalized macrophage depletion reduced the size and leakage of laser-induced CNV associated with decreased macrophage infiltration and VEGF protein expression. 7, 8 The process of angiogenesis is controlled by a variety of cells and molecular mediators. Macrophages can promote angiogenesis, and this promotive effect is thought to be related to its production of VEGF and a variety of inflammatory cytokines, such as ICAM-1, TNF-␣, and MMPs. 9 -12,44 Importantly, ICAM-1 is expressed on RPE and the vascular endothelial cell surface and is an important component of cell-to-cell interactions during inflammatory responses, mediating leukocyte (including macrophages) adhesion. 45 The expression of ICAM-1 in cultured human RPE cells is upregulated by the stimulation of IL-1␤ and TNF-␣. 46 TNF-␣ is a pleiotropic cytokine that mediates inflammatory, proliferative, and cytotoxic effects in a variety of cell types. 47 TNF-␣ contributes to the development of choroidal neovascularization through triggering VEGF production by RPE cells. 4 In addition, TNF-␣ enhances the expression of other angiogenic regulators such as MCP-1 and interleukins. Based on these facts, we can see there is a closed but amplifying circuit among VEGF, inflammatory cells (especially for macrophages), and inflammatory cytokines. 4, 48 The initial objective of this study was to use the anti-inflammatory property of 99 Tc-MDP to interrupt this inflammatory cascade circuit to inhibit CNV formation. Our cellular and molecular data showed that 99 Tc-MDP can inhibit macrophages infiltrating to the CNV and the downregulated expression of VEGF, ICAM-1, and TNF-␣. Based these data, we put forward a hypothesis for the mechanisms of inhibiting the effect of 99 Tc-MDP on CNV as follows. First, 99 Tc-MDP decreases the number of macrophages infiltrating the CNV. Macrophages are the main sources of VEGF, which is a critical angiogenic factor in CNV formation; therefore, the production of VEGF protein will be reduced. Second, reductions in the release of TNF-␣ due to the decreased numbers of macrophages can weaken ICAM-1 expression in endothelial cells and RPE cells, which will mediate fewer macrophages adhering to the CNV area. As a result, less VEGF protein will be produced, and CNV development will be suppressed. In addition, the in vitro experiments showed that 99 Tc-MDP could affect the downstream signaling transduction that stimulates the proliferation, migration, and tube formation of endothelial cells after VEGF binding to its receptors. Therefore, 99 Tc-MDP not only reduces VEGF expression in vivo (Fig. 3C) , it also blocks the function of already existing VEGF in vitro (Figs. 8, 9 ). This multiple targeting sites of 99 Tc-MDP on VEGF may partially explain the inhibitive effects of 99 Tc-MDP on the development of CNV, though the exact mechanisms have not been disclosed completely.
The 99 Tc-MDP used in our study is different from the agent 99m Tc-MDP (a radioactive imaging agent widely used for bone scintigraphy). Actually, 99 Tc-MDP is the decay product of 99m Tc-MDP. 99 Tc-MDP has little radioactivity, and this small amount of radioactivity has been demonstrated to be harmless to the human body in prolonged systemic administration in the clinical treatment of systemic inflammatory diseases such as RA and AS in China. 14 -17 Because of its powerful anti-inflammatory effect and its safety, we chose 99 Tc-MDP but not 99m Tc-MDP for our experiment. Significantly, electroretinography and cytotoxicity showed that any dose of 99 Tc-MDP used in our study was not toxic to the mouse retina (Fig. 6) or to nondividing (confluent) cells (Fig. 7B) . Furthermore, in our in vivo study, we found no body weight changes (data not shown) or mouse deaths caused by the injection of 99 Tc-MDP. Based on these facts, we believe that 99 Tc-MDP is a safe and effective anti-inflammatory agent.
In summary, our experimental data showed that 99 Tc-MDP can affect multiple inflammatory steps during CNV development, including MMP-2-mediated extracellular matrix degradation, recruitment of macrophages mediated by ICAM-1, and downregulated expressions of VEGF and inflammatory cytokines derived from macrophages. However, though 99 Tc-MDP reduces CNV formation significantly, the incidence rate of CNV between the 99 Tc-MDP treatment groups and the PBS treatment group are of no statistical significance (data not shown), suggesting that mechanisms other than inflammatory ones are involved in the angiogenesis of laser-induced CNV. In addition, as was shown in Figures 7A and 7B , 99 Tc-MDP had a specific inhibiting effect only on proliferating cells but not on nonproliferating cells, suggesting that 99 Tc-MDP might help to inhibit those active CNV lesions. However, pathologic mechanisms of CNV murine models are different from those of human beings. Therefore, the effects of 99 Tc-MDP on human beings still must be confirmed in clinical studies.
All these findings support the idea that inflammatory mechanisms play an important role in the pathogenesis of CNV and suggest that 99 Tc-MDP has therapeutic potential to inhibit CNV. Whereas there is still little knowledge about the effects of 99 Tc-MDP on CNV, further studies concerning long-term inhibitive effects and more detailed mechanisms of CNV inhibition are needed. 
